CLASS II Drug recall · Reported 29 Jan 2014 · FDA Enforcement Report
Theraflu Exte (dextromethorphan hydrobromide 20 mg recalled
Novartis Consumer Health is recalling Theraflu Exte (dextromethorphan hydrobromide 20 mg, phenylephrine hydrochloride 20 mg, distributed nationwide in the US. The recall was initiated on 18 Jun 2013 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-762-2014
- FDA event ID
- 65490
- Recalling firm
- Novartis Consumer Health, Lincoln, NE
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 18 Jun 2013
- FDA classified
- 17 Jan 2014
- Reported
- 29 Jan 2014
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Packaging Defects
- Drug class
- Allergy Medication
Timeline
| 18 Jun 2013 | Recall initiated by company | |
| 17 Jan 2014 | Classified by FDA | +213 days |
| 29 Jan 2014 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
Theraflu Exte (dextromethorphan hydrobromide 20 mg, phenylephrine hydrochloride 20 mg, chlorpheniramine maleate 10 mg) powder packets, lemon flavor, packaged in a) 6-count packets per carton (UPC 7 501124 812881) and b) 10-count packets per carton (UPC 7 501124 814595), Distributed by Novartis Farmaceutica, S.A., DE C.V., Mexico.
Where it was distributed
Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.
Questions about this recall
Why was it recalled?
Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.
Which lots are affected?
Lot #: a) 10119730, Exp 9/30/2013; b) 10115568, 10115570, Exp 6/30/2013; 10119728, Exp 9/30/2013.
Where was it sold?
Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
15 other products · FDA event 65490This product is part of a recall event; the main page for the event is NeoCitran Extra Strength Cold & Flu (acetaminophen 650 mg recalled.
More recalls from Novartis Consumer Health
All 60| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Food | CLASS II | Benefiber fiber supplement stick packs, sugar free and taste free recalledBenefiber | Novartis Consumer Health | Packaging Defects | Nationwide |
| Drug | CLASS II | Theraflu Flu & Sore Throat (acetaminophen 650 mg recalled | Novartis Consumer Health | Packaging Defects | Nationwide |
| Drug | CLASS II | Theraflu Nighttime Severe Cold & Cough recalled | Novartis Consumer Health | Packaging Defects | Nationwide |
| Drug | CLASS II | Theraflu Flu & Chest Congestion (acetaminophen 1000 mg recalled | Novartis Consumer Health | Other | Nationwide |
| Drug | CLASS II | NeoCitran Extra Strength Non-Drowsy Cold & Sinus recalled | Novartis Consumer Health | Packaging Defects | Nationwide |